The global cardiac assist devices market is poised to surpass US$ 1.37 billion by 2023, surging at a remarkable CAGR of 6.1% through 2033 to reach US$ 2.48 billion.
The incorporation of advanced technology such as the Internet of Thinking and rising investment from leading players results in market growth.
The technologies utilized to create cardiac devices have advanced dramatically during the past ten years, and so have the indications for these devices. Due to this, many patients are now being handled with cardiology devices, which have had exponential therapeutic and monitoring outcomes.
The development that has had a big positive effect on cardiology is artificial intelligence, which has increased diagnostic skills for some cardiac disorders.
Attributes | Details |
---|---|
Cardiac Assist Devices Market Estimated Value (2023) | US$ 1.37 billion |
Cardiac Assist Devices Market Estimated Value (2033) | US$ 2.48 billion |
Cardiac Assist Devices Market Value CAGR (2023 to 2033) | 6.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Cardiac Assist Devices Market recorded steady growth of 5.8% CAGR during the historical period, from 2018 to 2022. The rising prevalence of heart failure across the globe resulted in increased demand for cardiac assist devices.
Technological development in the field of ventricular assist devices is recognized as a key driver for the growth of the cardiac assist devices industry with mounting cases of coronary heart diseases.
As per FMI’s analysis, growth in cardiac assist devices is attributed to the increasing prevalence of lifestyle disorders that are the main cause of cardiovascular diseases. Cardiovascular diseases such as coronary heart disease and others have led to increased cases of heart failure, especially across the United States of America, the United Kingdom, and India.
Demand for heart transplantation has significantly increased due to the rising cases of heart failure. However, the unavailability of heart donors and long waiting list result in increased mortality rates.
Patients are hence opting for ventricular assist devices for the treatment of heart failure. Due to the increased demand for ventricular assist devices, leading companies are continuously developing advanced cardiac assist devices catering to the demand. Moreover, key companies are adopting cutting-edge technologies such as artificial intelligence and the Internet of Thinking to facilitate the rising demand and curb mortality rates.
As per FMI, the market witnessed a year-on-year (Y-o-Y) growth at 6.1% CAGR, topping US$ 2.48 billion in 2033.
Over the past few years, the United States of America has been in the lead in terms of healthcare. Increasing cases of cardiovascular disease contributed to the country’s market share of 51.7% in 2022.
Technological advancements in the field of cardiac assist devices are one of the key factors driving growth. The rising prevalence of heart failure within the country has increased the demand for ventricular assist devices. Furthermore, healthcare professionals and scientists are incessantly working on developing next-generation ventricular assist devices.
Thanks to the presence of leading players such as Medtronic PLC., and Abbott Laboratories, the development of cardiac assist devices and new launches, have significantly improved the market revenue.
Increasing preference for non-invasive, portable, and implantable devices has also accelerated the market growth in the country. Leading healthcare companies are developing products in the pipeline focusing on minimally invasive ventricular assist devices. For instance,
With the rising incidence of cardiovascular disease in the country, the number of heart transplant surgeries is increasing at a mounting pace. However, the severe shortage of organ donors has resulted in increasing demand for heart devices. The increasing number of patients opting for cardiac assist devices in the United States of America fuels the market growth during the forecast period.
As per Future Market Insights, India is anticipated to be one of the highly profitable markets of South Asia in the cardiac assist devices market with a projected CAGR of 5.1% from 2023 to 2033.
The expansion of the healthcare sector and the development of ventricular assist devices are affecting the market growth positively. The prevalence of heart failure in the country has resulted in increased demand for cardiac assist devices. Additionally, increased government funding and initiatives for the development of healthcare facilities are likely to boost growth across India.
India is the top country with a high diabetic population, and nearly 77 million people suffer from diabetes, estimates International Diabetes Federation. Diabetes is the primary cause of developing major heart disease. One-fifth of the Indian population succumb due to coronary heart disease.
India is witnessing a simultaneous uptick in the number of heart failure, especially among the younger population due to the rising cases of coronary heart disease. With the increasing burden of heart failure in the country, patients are opting for minimally invasive procedures. This, in turn, has increased the demand for ventricular assist devices, especially left ventricular assist devices in India.
Growing government funding and initiatives are also aiding the growth of the cardiac assist devices market. For instance, the Government of Assam Health and Family Welfare has introduced a scheme in which government bears the expenses of surgery for children with coronary heart disease.
Growth in the United Kingdom for cardiac assist devices is attributable to the increasing technological advancements in the field of ventricular assist devices, where the United Kingdom garnered a revenue share of 6.4% in 2022.
With the rising prevalence of coronary heart diseases resulting in heart failure, the adoption of ventricular assist devices is improving. Furthermore, the expansion of healthcare infrastructure and leading companies focusing on the development of next-generation cardiac assist devices have improved the adoption of ventricular assist devices.
Leading player based in the United Kingdom, Calon Cardio-Technology, for instance, intends to receive CE marking fulfilling the European products requirement for its ventricular assist device, commonly known as, MiniVAD.
Increasing investment in the development of these devices is creating incremental opportunities for cardiac assist devices in the country. With patients now opting for minimally invasive devices for the treatment of heart failure, demand for ventricular assist devices is burgeoning across the United Kingdom.
As per Future Market Insights, Germany is anticipated to lead the growth of Europe’s cardiac assist market, holding a value share of 11.2% in 2022 globally.
Technological advancements and innovation in ventricular assist devices are key growth factors driving the demand for cardiac assist devices in Germany. Moreover, companies are investing hugely in the development of cardiac assist devices to cater to the increasing demand.
Increasing initiatives and funding from the government are also aiding the growth of the cardiac assist devices market in Germany. Further, leading players such as Biotronik, are developing next-generation implantable and ventricular assist devices for patients suffering from heart failure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Accounting for over 62.49% of global revenue share, ventricular assist devices are anticipated to be highly sought-after in the cardiac assist devices industry. Increasing demand for left ventricular assist devices in aiding the growth of VAD.
Future Market Insights estimates VAD to be the product of choice in the market. As healthcare professionals and engineers are developing next-generation devices fully implantable on both sides of the heart, ventricular assist devices are expected to gain traction.
Growth in this segment is attributed to technological advancements, the rising prevalence of cardiac arrest, and the shortage of organ donors. Also, advancements and upgradation in the development of LVAD have bolstered its adoption.
Leading healthcare companies such as Abbott Laboratories, Medtronic PLC, and Abiomed are increasing research activities to develop advanced LVAD catering to the rising demand. With rapid development, companies are seeking fast-track approvals from regulatory bodies which are resulting in high investment.
With the increasing demand for technologically updated ventricular assist devices, the market is expected to register high demand in the next decade.
Based on modality type, the market is segmented into transcutaneous and implantable cardiac assist devices. As per Future Market Insights, the implantable devices segment captured a share of 60.79% in 2022.
Owing to the benefits of the ability to screen, monitor, and control erratic heart rhythms, implantable devices are expected to gain immense popularity during the forecast period. Moreover, the rising need for efficient solutions to manage heart failure is predicted to improve the adoption of implantable devices. Additionally, increasing preference for non-invasive surgical procedures has accelerated the adoption of implantable devices.
An implantable cardioverter defibrillator is a useful device that helps prevent sudden death in patients suffering from sustained ventricular tachycardia or fibrillation. Technological advancements and gradation in implantable cardiac assist devices have improved the demand.
Hospital pharmacies are gaining popularity as the primary end-user in the healthcare industry due to several reasons that are contributing to the sub-segment share of 79.8% in 2022.
Firstly, hospital pharmacies offer a centralized and convenient source of medication procurement and distribution within the hospital setting. This ensures efficient inventory management, reduces medication errors, and improves patient safety.
Secondly, hospital pharmacies provide specialized pharmaceutical services, including compounding, drug information, and medication management, tailored to the unique needs of the hospital and its patients.
Lastly, with the increasing complexity of medication therapies and the need for close collaboration with healthcare providers, hospital pharmacies play a vital role in ensuring optimal patient outcomes and medication utilization.
As per FMI’s analysis, continuous innovation and gradation in cardiac assist devices have led to intense competition among top market players.
Key players are focusing on new product launches and gaining approvals from regulatory bodies to stay in the competition. Nearly 75% of the global market share is accounted for by the top 7 players operating in the cardiac assist devices market.
Organizations are also adopting winning strategies such as collaborations and mergers among key players. These strategies are also adopted by regional players to gain a leading position in the industry.
Developments in the Market:
The cardiac assist devices market value reaches US$ 1.37 billion in 2023.
The cardiac assist devices market is anticipated to surpass US$ 2.48 billion by 2033, recording a CAGR of 6.1%.
The implantable cardiac assist devices segment is likely to gain prominence, holding 60.79% of market revenue.
The United States boasts lucrative potential for cardiac assist devices with advanced healthcare infrastructure and increasing cardiovascular conditions.
Key cardiac assist devices market players are Terumo Corporation, Medtronic PLC, Abbott Laboratories, Abiomed Inc., Teleflex Incorporated, Maquet GmbH, BerlinHeart GmbH, and others.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Ventricular Assist Devices (VAD) 5.3.1.1. Left Ventricular Assist Device (LVAD) 5.3.1.2. Right Ventricular Assist Device (RVAD) 5.3.1.3. Biventricular Assist Device (BIVAD) 5.3.1.4. External Ventricular Assist Devices 5.3.2. Intra-Aortic Balloon Pump 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Modality Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality Type, 2023 to 2033 6.3.1. Transcutaneous 6.3.2. Implantable 6.4. Y-o-Y Growth Trend Analysis By Modality Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Modality Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033 7.3.1. Hospital 7.3.2. Ambulatory Surgical Centers 7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Modality Type 9.2.4. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Modality Type 9.3.4. By End-User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Modality Type 10.2.4. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Modality Type 10.3.4. By End-User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Modality Type 11.2.4. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Modality Type 11.3.4. By End-User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Modality Type 12.2.4. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Modality Type 12.3.4. By End-User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Modality Type 13.2.4. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Modality Type 13.3.4. By End-User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Modality Type 14.2.4. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Modality Type 14.3.4. By End-User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Modality Type 15.2.4. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Modality Type 15.3.4. By End-User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Modality Type 16.1.2.3. By End-User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Modality Type 16.2.2.3. By End-User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Modality Type 16.3.2.3. By End-User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Modality Type 16.4.2.3. By End-User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Modality Type 16.5.2.3. By End-User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Modality Type 16.6.2.3. By End-User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Modality Type 16.7.2.3. By End-User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Modality Type 16.8.2.3. By End-User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Modality Type 16.9.2.3. By End-User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Modality Type 16.10.2.3. By End-User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Modality Type 16.11.2.3. By End-User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Modality Type 16.12.2.3. By End-User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Modality Type 16.13.2.3. By End-User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Modality Type 16.14.2.3. By End-User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Modality Type 16.15.2.3. By End-User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Modality Type 16.16.2.3. By End-User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Modality Type 16.17.2.3. By End-User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Modality Type 16.18.2.3. By End-User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Modality Type 16.19.2.3. By End-User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Modality Type 16.20.2.3. By End-User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Modality Type 16.21.2.3. By End-User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Modality Type 16.22.2.3. By End-User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Modality Type 16.23.2.3. By End-User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Modality Type 17.3.4. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Terumo Corporation 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Medtronic PLC 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Abbott Laboratories 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Abiomed Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Teleflex Incorporated 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Maquet GmbH 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. BerlinHeart GmbH 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports